Why Kewaunee Scientific Corporation’s (KEQU) Stock Is Up 5.86%
As of Monday, November 02, Kewaunee Scientific Corporation’s KEQU share price has surged by 5.86%, which has investors questioning if this is right time to sell.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Jenna Brashear
Rosalio Madrigal
Jenna Brashear
Jenna Brashear
| Share Statistics | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $98.8 | $402.1 | 22% |
|
| Shares Out (Mil) | 2.9 | 40.6 | 10% |
|
| Institutional Ownership | 62.1% | 83.5% | 40% |
|
| Float (Mil) | 2.2 | 35.2 | 6% |
|
| Beta | 0.73 | 0.85 | 43% |
|
| Avg Daily Volume (000s) | 7 | 373 | 16% |
|
| Price Change (52-week) |
(18.4%) | 63.1% | 36% |
|
| Growth | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 13.8% | 11.8% | 70% |
|
| Net Income (5yr) | 35.7% | (5.6%) | 89% |
|
| EPS (5yr) | 34.6% | 10.6% | 85 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (64.9%) | (15.6%) | 3% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $277 | $127 | 35% |
|
| Net Income (TTM) (Mil) | $8 | ($9) | 44% |
|
| EPS (TTM) | $2.868 | ($0.300) | 77% |
|
| Operating Cash Flow (TTM) (Mil) | $15 | ($1) | 39% |
|
| Net Cash Flow (TTM) (Mil) | ($10) | $2 | 31% |
|
| Long-Term Debt (Q1) (Mil) | $45 | $27 | 38% |
|
| Enterprise Value (Q1) (Mil) | $148 | $390 | 24% |
|
| Valuation | KEQU | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.32 | 2.54 | 38% |
|
| P/E | 12.3 | 26.2 | 30% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.4 | 1.4 | 18% |
|
| Ratios | KEQU | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 28.6% | 59.5% | 33% |
|
| Net Margin | 3.0% | (4.6%) | 40% |
|
| ROA | 4.5% | (10.8%) | 68% |
|
| ROE | 11.6% | (9.4%) | 61% |
|
| Liabilities to Assets | 56.1% | 46.0% | 49% |
|
| F-Score | 4 | 4 | 33% |
|
Kewaunee Scientific Corporation did not pass any screens on 11/6/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors